What can we do for patients who develop rashes associated with cancer chemotherapies?
Skin rash is a major side effect of erlotinib therapy; however, it can also be seen with other chemotherapies. Treatment for rashes should include determining the severity of the rash using a grading system of 1 to 4. For grade 1 and grade 2 rashes, use of Regenecare wound gel or a corticosteroid cream 4 times daily seems to lessen the itching, pain, and redness.
For grade 3 rashes, a 4% erythromycin ointment used 2 to 3 times daily, after washing with warm water and a mild, nondrying soap, is reported as effective. Chemotherapy dose reductions or discontinuation of therapy should be considered for patients with grade 4 rashes. — Rosemarie A. Tucci, RN, MSN
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.